Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples